Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading Window
Intimation of Closure of Trading Window26-06-2024
26-06-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.22-06-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.10-06-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Submission of Annual Secretarial Compliance Report for the Financial Year ended 31 March 2024 (2023-24).23-05-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings call held on 03 May 2024 post announcement of the financial results of the Company for the quarter and financial year ended 31 March 2024.07-05-2024
Tatva Chintan Q4 Results Review - Revenue May Rise 25% With Expansion In Margin: ICICI Securities
Gross profit margin up 215 bps QoQ to 57.8%07-05-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Extract of Financial Results of the Company for the Quarter and Financial Year Ended 31 March 2024.04-05-2024
Tatva Chintan Pharma Q4 Results: Profit Falls 43%
The specialty chemical manufacturer's profit declined to Rs 9.6 crore in the quarter-ended March.03-05-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for Initial Public Offering ("IPO") for the quarter ended 31 March 2024.03-05-2024